Xi Chen
Vorstandsvorsitzender bei Rootpath Genomics, Inc.
Profil
Founder of Rootpath Genomics, Inc., Xi Chen presently holds the position of Chief Executive Officer at Rootpath Genomics, Inc. and Venture Partner at Nest.Bio Ventures.
Dr. Chen received a graduate degree from The University of Texas at Austin and an undergraduate degree from Shanghai Jiao Tong University.
Aktive Positionen von Xi Chen
| Unternehmen | Position | Beginn |
|---|---|---|
Rootpath Genomics, Inc.
 Rootpath Genomics, Inc. BiotechnologyHealth Technology Rootpath Genomics, Inc. engages in the provision of biotechnology services. It develops personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy. The company was founded by Xi Chen, Le Cong, Yinqing Li, Cheryl Cui, and Ely Porter in 2017 and is headquartered in Cambridge, MA. | Vorstandsvorsitzender | 01.01.2017 |
Nest.Bio Ventures
 Nest.Bio Ventures Investment ManagersFinance Nest.Bio Ventures (Nest.Bio) is a venture capital firm founded in 2017. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 01.06.2016 |
Ausbildung von Xi Chen
| The University of Texas at Austin | Graduate Degree |
| Shanghai Jiao Tong University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Rootpath Genomics, Inc.
Rootpath Genomics, Inc. BiotechnologyHealth Technology Rootpath Genomics, Inc. engages in the provision of biotechnology services. It develops personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy. The company was founded by Xi Chen, Le Cong, Yinqing Li, Cheryl Cui, and Ely Porter in 2017 and is headquartered in Cambridge, MA. | Health Technology |
Nest.Bio Ventures
Nest.Bio Ventures Investment ManagersFinance Nest.Bio Ventures (Nest.Bio) is a venture capital firm founded in 2017. The firm is headquartered in Cambridge, Massachusetts. | Finance |
